Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline Summary
Author:
Affiliation:
1. University of Michigan Health System, Ann Arbor, MI
2. American Society of Clinical Oncology, Alexandria, VA
3. Weill Cornell Medicine/Cornell University, New York, NY
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Oncology (nursing),Health Policy,Oncology
Link
https://ascopubs.org/doi/pdfdirect/10.1200/JOP.19.00722
Reference15 articles.
1. Surveillance Imaging in Patients with Resected Non–Small Cell Lung Cancer: Too Much, Not Enough, or Just Right?
2. Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence
3. Salvage Stereotactic Body Radiation Therapy (SBRT) for Local Failure After Primary Lung SBRT
4. Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
5. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Decision Regret among Patients with Early-stage Lung Cancer Undergoing Radiation Therapy or Surgical Resection;Clinical Oncology;2023-06
2. Lung Cancer Screening Eligibility and Referral Practices in Texas Organizations Serving People with Substance Use Disorders;Cancers;2023-03-30
3. A risk model including eight tumor microenvironment-related genes for prediction of lung cancer prognosis;2022-08-17
4. Whole Transcriptome Analysis Identifies Platycodin D-Mediated RNA Regulatory Network in Non–Small-Cell Lung Cancer;Cells;2022-08-01
5. Prognosis for Pneumonic-Type Invasive Mucinous Adenocarcinoma in a Single Lobe on CT: Is It Reasonable to Designate It as Clinical T3?;Korean Journal of Radiology;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3